CVS Health Corporation (TSX:CVS)
Canada flag Canada · Delayed Price · Currency is CAD
21.28
-0.11 (-0.51%)
Nov 13, 2026, 4:00 PM EST

CVS Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
418,158399,834370,656356,623321,629290,912
Revenue Growth
6.76%7.87%3.94%10.88%10.56%8.59%
Cost of Revenue
360,776346,705321,408303,345267,965239,991
Gross Profit
57,38253,12949,24853,27853,66450,921
Selling, General & Admin
44,60843,11041,22939,20537,92236,764
Operating Expenses
44,60843,11041,22939,20537,92236,764
Operating Income
12,77410,0198,01914,07315,74214,157
Interest Expense
-3,065-3,119-2,958-2,658-2,287-2,503
Interest & Investment Income
2,4562,2332,1531,1538381,199
Other Non Operating Income (Expenses)
5-5-5-6-4-4
EBT Excluding Unusual Items
12,1709,1287,20912,56214,28912,849
Merger & Restructuring Charges
-52-210-1,452-1,040-117-1,490
Impairment of Goodwill
--5,725----431
Gain (Loss) on Sale of Assets
-483--349-2,533-
Legal Settlements
--1,540-100--5,803-
Other Unusual Items
--491---391
Pretax Income
12,1182,1366,14811,1735,83610,537
Income Tax Expense
1,0724081,5622,8051,5092,548
Earnings From Continuing Operations
11,0461,7284,5868,3684,3277,989
Net Income to Company
11,0461,7284,5868,3684,3277,989
Minority Interest in Earnings
-94028-24-1612
Net Income
11,0371,7684,6148,3444,3118,001
Net Income to Common
11,0371,7684,6148,3444,3118,001
Net Income Growth
2253.30%-61.68%-44.70%93.55%-46.12%11.45%
Shares Outstanding (Basic)
1,2761,2671,2591,2851,3121,319
Shares Outstanding (Diluted)
1,2861,2711,2621,2901,3231,329
Shares Change
1.66%0.71%-2.17%-2.49%-0.45%1.14%
EPS (Basic)
8.651.403.666.493.296.07
EPS (Diluted)
8.581.393.666.473.266.02
EPS Growth
2214.05%-62.02%-43.43%98.47%-45.85%10.19%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,5677,8076,32610,39513,45015,745
Free Cash Flow Per Share
12.116.145.018.0610.1711.85
Dividend Per Share
2.6602.6602.6602.4202.2002.000
Dividend Growth
0%0%9.92%10.00%10.00%0%
Gross Margin
13.72%13.29%13.29%14.94%16.68%17.50%
Operating Margin
3.06%2.51%2.16%3.95%4.89%4.87%
Profit Margin
2.64%0.44%1.24%2.34%1.34%2.75%
Free Cash Flow Margin
3.72%1.95%1.71%2.92%4.18%5.41%
EBITDA
17,29414,62512,61618,43919,96618,643
EBITDA Margin
4.14%3.66%3.40%5.17%6.21%6.41%
D&A For EBITDA
4,5204,6064,5974,3664,2244,486
EBIT
12,77410,0198,01914,07315,74214,157
EBIT Margin
3.06%2.51%2.16%3.95%4.89%4.87%
Effective Tax Rate
8.85%19.10%25.41%25.11%25.86%24.18%
Revenue as Reported
420,614402,067372,809357,776322,467292,111
Advertising Expenses
-970989985745707